By: Stock Blog Hub
October 28, 2010 at 16:32 PM EDT
(ACAD) Acadia Pharmaceuticals Gets Pimavanserin Back
This morning, Acadia Pharmaceuticals (ACAD) announced that it has entered into an agreement with Biovail Labs (BLS), a wholly owned subsidiary of Valeant Pharmaceuticals International, to conclude the previously established collaboration to develop and commercialize pimavanserin in the U.S. and Canada. Acadia has now reclaimed global rights to the drug. As part of the transaction, Biovail [...] (ACAD) Acadia Pharmaceuticals Gets Pimavanserin Back
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here